Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Scardino
    Scardino
  5. Eastham
    Eastham
  6. Jarnagin
    Jarnagin
  7. Reuter
    Reuter
  8. D'Angelica
    D'Angelica
  9. Kingham
    Kingham
  10. Ladanyi
    Ladanyi

Groups

  1. Surgery (2075)
  2. Department of Medicine (1355)
  3. Urology (1171)
  4. Solid Tumor Oncology Division (842)
  5. Population Sciences Research Program (830)
  6. Survivorship Research (727)
  7. Epidemiology and Biostatistics (694)
  8. Sloan Kettering Institute Faculty (603)
  9. Department of Pathology and Laboratory Medicine (594)
  10. GSK Faculty (585)
Search Within
Formats
  1. Journal Article (3921)
  2. Meeting Abstract (1056)
  3. Editorial (181)
  4. Review (142)
  5. Correspondence (121)
  6. Guidelines (83)
  7. Research Letter (33)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2075)
  2. Department of Medicine (1355)
  3. Urology (1171)
  4. Solid Tumor Oncology Division (842)
  5. Population Sciences Research Program (830)
  6. Survivorship Research (727)

More Groups

People
  1. Harry Herr (271)
  2. Andrew Vickers (229)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (163)
  6. William Jarnagin (159)

More People

Years
  1. 2025 (167)
  2. 2024 (255)
  3. 2023 (235)
  4. 2022 (263)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (768)
  2. European Urology (580)
  3. Lancet Oncology (405)
  4. Urology (392)
  5. Journal of the American College of Surgeons (348)
  6. Journal of Molecular Diagnostics (277)

More Publications

Results (5572)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-time indocyanine green imaging to aid in closure of radiated wounds
    Correspondence

    Shahzad, F.; Fabbri, N.
    Journal of Plastic Reconstructive and Aesthetic Surgery (2024)

    Fulltext@MSK | Save
  • Convolutional network denoising for acceleration of multi-shot diffusion MRI
    Journal Article

    Alus, O.; El Homsi, M.; Golia Pernicka, J. S.; Rodriguez, L.; Mazaheri, Y.; Kee, Y.; Petkovska, I.; Otazo, R.
    Magnetic Resonance Imaging (2024)

    Fulltext@MSK | Save
  • Health-related quality-of-life of patients treated with repotrectinib for neurotrophic tyrosine receptor kinase (NTRK)-positive advanced solid tumors: Results from TRIDENT-1
    Meeting Abstract

    Sherif, B.; Besse, B.; Solomon, B.; Bazhenova, L.; Kim, D. W.; Lin, J. J.; Wolf, J.; Popat, S.; Goto, K.; de Langen, A. J.; more...
    Value in Health (2023)

    Fulltext@MSK | Save
  • Role of inpatient rehabilitation in managing delirium: A review
    Meeting Abstract

    Ghosh, S.; Ganguly, A.
    Journal of the Academy of Consultation-Liaison Psychiatry (2023)

    Fulltext@MSK | Save
  • An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States
    Meeting Abstract

    Oluwole, O.; Patel, A.; Vadgama, S.; Smith, N.; Blissett, R. S.; Feng, C.; Dickinson, M.; Johnston, P.; Perales, M. A.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Comparative effectiveness of teclistamab versus real-world physician's choice of therapy (RWPC) for patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Krishnan, A.; Nooka, A.; Chari, A.; Garfall, A. L.; Martin, T.; Nair, S.; Lin, X.; Qi, K.; Londhe, A.; Pei, L.; more...
    Value in Health (2023)

    Fulltext@MSK | Save
  • Adjusted comparison of teclistamab versus real-world physician's choice (RWPC) of therapy in patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Mateos, M. V.; Chari, A.; Usmani, S. Z.; Goldschmidt, H.; Weisel, K.; Qi, K.; Londhe, A.; Nair, S.; Lin, X.; Pei, L.; more...
    Value in Health (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect treatment comparison (MAIC) of teclistamab vs belantamab mafodotin for the treatment of patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Moreau, P.; Usmani, S. Z.; van de Donk, N. W. C. J.; Garfall, A. L.; Delforge, M.; Oriol, A.; Nooka, A.; Rosiñol, L.; Bahlis, N.; Otero, P. R.; more...
    Value in Health (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect treatment comparison (MAIC) of teclistamab versus selinexor-dexamethasone for the treatment of patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Moreau, P.; Usmani, S. Z.; van de Donk, N. W. C. J.; Garfall, A. L.; Delforge, M.; Oriol, A.; Nooka, A.; Rosiñol, L.; Bahlis, N.; Rodriguez Otero, P.; more...
    Value in Health (2023)

    Fulltext@MSK | Save
  • 3D genomics identify alternate mechanisms of homologous recombination deficiency in uterine sarcoma
    Meeting Abstract

    Schmitt, A.; Chiang, S.; Hensley, M.; Vasudevaraja, V.; Tran, I.; Yang, Y.; Stewart, C.; Park, K.; Ellenson, L.; Sikkink, K.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save